inFLUenza

National Influenza Strategy Group

HomeAbout NISGAbout InfluenzaWho is EligibleThe VaccinesFAQResourcesPandemicAntiviralsContacts
Last Updated: Monday, 8 February 2010

CONTACTS

USEFUL CONTACT INFORMATION

Ordering vaccine:
All influenza vaccine ordering is being handled by Healthcare Logistics (HCL).  You can order in two ways:
Online:                  www.hconline.co.nz
Fax order forms:    0508 408 358

For questions about ordering vaccine, contact HCL on their Customer Service line: 0508 425 358

Influenza Vaccine Order Form click here

Medical Queries
For medical questions about the vaccine contact the distributing companie

For questions on Fluvax®: contact CSL Biotherapies
                                                       Phone: 0800 502 757

For questions on VAXIGRIP®: contact sanofi aventis
                                                       Phone: 0800 727 838

For questions on INFLUVAC®: contact Solvay Pharmaceuticals
                                                       Phone: 0800 584 212

For questions on antiviral medication: contact Roche Products
                                                       Phone: 0800 656 464

For information on claiming funded vaccine:
Call Sector Services Help Desk on 0800 281 222 press 4. For manual forms call Wickliffe on 0800 259 138 and quote your Sector Services payee number as your customer number. If you do not know your patient’s NHI number phone Sector Services on 0800 855 151.

For further enquires regarding patient eligibility and technical queries contact:
Immunisation Advisory Centre.
Phone (0800 466 863)  or email - 0800IMMUNE@auckland.ac.nz
Check with the Ministry of Health website – www.moh.govt.nz/influenza

For queries related to payments made through Sector Services:
Contact the customer services team on 0800 458 448, alternatively fax your query to 04 381 5344.

For information on the national influenza immunisation campaign:
National Influenza Co-ordinator - email: influenza@auckland.ac.nz
Your district facilitator or local immunisation coordinator may be able to assist with more information and additional resources to suit your region.
Phone: (09) 373 7599 ext. 82012

For general information on immunisation:
The Immunisation Advisory Centre (IMAC) on 0800 IMMUNE (0800 466 863), or visit www.immune.org.nz

Centre for Adverse Reactions Monitoring (CARM):
Health Professionals can report any adverse reaction to influenza vaccination online at CARM’s website: www.carm.otago.ac.nz (use your practice number as login) or on the standard CARM reporting form (also available online) or by telephone: (03) 479 7247, fax: (03) 479 7150 or email: carmnz@stonebow.otago.ac.nz
Post: NZ Phv, University of Otago, Medical School, P O Box 913, Dunedin 9054.

Other useful websites:

Centre for Adverse Reactions Monitoring (CARM) – http://carm.otago.ac.nz

Center for Disease Control and Prevention (contains links to influenza updates, patient education and the Morbidity and Mortality Weekly Report – www.cdc.gov/flu/ 

CSL Biotherapies - www.cslbiotherapies.co.nz

Flu Vaccine Formulation, New Zealand Medicines and Medical devices Safety Authority - www.medsafe.govt.nz/regulatory/flu.asp

Medsafe - www.medsafe.govt.nz

NICS National Institute of Clinical Studies - www.fightflu.com.au 

Pro Pharma - www.propharma.co.nz

sanofi pasteur’s influenza.com website – www.influenza.com

Solvay Pharmaceuticals - www.solvay.com.au

WHO Collaborating Centre for reference and research on influenza, (Australia) – www.influenzacentre.org

WHO recommendations for influenza vaccine composition for the Southern hemisphere 2010 - www.who.int/csr/disease/influenza/recommendation2010south/en/index.html

WHO recommendations for influenza vaccine composition for the Northern hemisphere (2009-2010) - www.who.int/csr/disease/influenza/recommendations2009_10north/en/

World Health Organization (WHO) – www.who.int/en 

Ministry of Health - Pandemic Influenza - www.moh.govt.nz/influenza-a-h1n1

 


Top  |  Home  |  Print Page

Immune Advisory Centre Fluvax®, Vaxigrip® & Influvac® are Prescription Medicines. Contain inactivated strains of influenza vaccine for the prevention of influenza Types A & B. Specific types to be notified. Fluvax® CSL Biotherapies, Auckland. Vaxigrip® Sanofi Pasteur, Marketed by sanofi-aventis, Auckland, Influvac® Solvay Pharmaceuticals, Australia. Please read the brochure or consent form and talk to your doctor about the benefits and any possible side effects. For More information ring 0800 466 863.
TAPS NA 9998
Copyright © 2005 Immunisation Advisory Centre. All Rights Reserved. Web design by Insight & CMS by DMD Internet. .